Cargando…

Immunotherapy or targeted therapy as the first-line strategies for unresectable hepatocellular carcinoma: A network meta-analysis and cost-effectiveness analysis

INTRODUCTION: The existence of many phase III randomized controlled trials (RCTs) of first-line treatment for unresectable hepatocellular carcinoma (HCC) puzzle doctors and patients in choosing the most effective treatment strategies. We aimed to assess the efficacy, safety, and cost-effectiveness o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kun, Zhu, Youwen, Zhu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874298/
https://www.ncbi.nlm.nih.gov/pubmed/36713376
http://dx.doi.org/10.3389/fimmu.2022.1103055